Is Now The Time To Invest In Vertex Pharmaceuticals Incorporated (VRTX), Staples, Inc. (SPLS), and Lion Biotechnologies Inc (LBIO)?

Posted by admin December 18, 2014 0 Comment 1094 views

New York, NY – GDP INSIDER  –  12/18/2014.

This investment analysis discusses Vertex Pharmaceuticals Incorporated(NASDAQ:VRTX), Staples, Inc.(NASDAQ:SPLS), and Lion Biotechnologies Inc(OTCMKTS:LBIO)

Vertex Pharmaceuticals Incorporated(NASDAQ:VRTX) announced on Dec. 15th that David Altshuler, M.D., Ph.D., would be joining the company as its Executive Vice President of Global Research and Chief Financial Officer. Altshuler was previously a founding member of the Broad Institute of Harvard and MIT. The company had a high trading volume of 2.55 million yesterday, which is 0.82 million greater than its three month average volume of 1.73 million. Simply put, investor interest in Vertex Pharmaceuticals Incorporated is on the rise. The company has a beta of -1.01.

Take A Look At Our Free Analysis And Learn More About VRTX’s Direction.

Staples, Inc.(NASDAQ:SPLS) announced yesterday that its Canada division had released its third quarter 2014 sustainability report. The company surpassed its battery collection goal of 100,000 kg for the month of October. The stock traded for a new 52 week high of $17.46 before finishing yesterday’s trading at a new closing price of $!7.29 after a 0.23% boost of four cents. Staples Inc. appears to be on the rise. The company has a price to earnings ratio (TTM) of $18.57 and a market capitalization of $11.06 billion.

Will Staples Inc. Emerge As A Winner? View Our Free SPLS Analysis And Develop A Savvy Investment Plan.

Lion Biotechnologies Inc(OTCMKTS:LBIO) announced the pricing of an underwritten common stock offering yesterday. The company’s offering of 5,217,392 shares of common stock will be available at a price of $5.75 per share. The gross proceeds of the offering comes in at $30 million. The company had a high trading volume of 0.71 million yesterday, which is 0.66 million greater than its three month average volume of 0.05 million. These figures indicate that investor interest in Lion Biotechnologies Inc. is on the rise. The company has a one-year target estimate of $20.00 and finished yesterday’s trading at a closing price of $7.15.

Could Lion Biotechnologies Break Out? Make A Smart Investment Decision With Our Free LBIO Analysis.

About HotStockGains provides investors and traders with trading strategies via text message and email. To obtain text message stock alerts service text the word BREAKOUT to 555888 from your cell phone.

Additionally, HotStockGains free newsletter provides market insight, tips, and trading strategies on NYSE, NASDAQ, OTCBB and PINK stocks.

Disclosure:  HotStockGains is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Always seek help from a professional financial advisor (I am not one). Please visit for complete risks and disclosures.

Write Your Comment